Publication | Closed Access

Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II

HypertensionHeart FailureCardiac Angiotensin IiCardiomyopathyCardiovascular DiseaseRenal FunctionAtherosclerosisPhysiologyIncreased Blood PressureVascular BiologyMedicineCardiologyNephrologyProlylcarboxypeptidase Deficiency